Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026Adaptive Biotechnologies Corporation beats earnings expectations.
Adaptive Biotechnologies Corp (ADPT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 29,993,708 | $487,097,818 | 1.29% | |
| 2. | Driehaus Capital Richard Driehaus | 2,760,387 | $44,828,685 | -9% | 0.3% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,422,089 | $39,334,725 | -1% | 0.02% |
| 4. | ARK Investment Management Catherine D. Wood | 2,138,960 | $34,736,718 | -33% | 0.23% |
| 5. | D E Shaw D. E. Shaw | 1,902,685 | $30,899,604 | +158% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 2,500 | $50,000.00 | 2,500 | 2019-07-01 | Filing | |
| $20.00 | 1,000 | $20,000.00 | 1,000 | 2019-07-01 | Filing | |
| $20.00 | 300 | $6,000.00 | 300 | 2019-07-01 | Filing | |
| $20.00 | 400 | $8,000.00 | 400 | 2019-07-01 | Filing | |
| $20.00 | 500 | $10,000.00 | 500 | 2019-07-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.46 | 2,145 | $39,596.70 | 216,637 | 2026-02-04 | Filing | |
| $19.00 | 8,120 | $154,280.00 | 1,179,524 | 2026-02-03 | Filing | |
| $18.60 | 34,668 | $644,824.80 | 1,187,644 | 2026-02-02 | Filing | |
| $18.44 | 124,998 | $2,304,963.12 | 2,459,245 | 2026-02-02 | Filing | |
| $17.73 | 79,590 | $1,411,130.70 | 315,978 | 2026-01-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,333,559 | $216,536,989 | 0% | |
| 2. | 11,282,152 | $183,222,148 | 0% | |
| 3. | 4,060,481 | $65,942,211 | 0.27% | |
| 4. | 3,511,855 | $57,040,977 | 0% | |
| 5. | 3,181,644 | $51,669,899 | 0% |
News See All
Adaptive Biotechnologies (ADPT) Falls 24.5% as Execs Dispose Millions of Stake
In separate regulatory filings last week, Adaptive Biotechnologies Corp.
Adaptive Biotechnologies (ADPT) Hits 3-Year High. Here's Why
Among others, Adaptive Biotechnologies Corporation (NASDAQ:ADPT) said it expects its pharmaceutical services to generate $20 million in revenues, and anticipates EMR integrated testing volumes to exceed...
Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor letter. The letter highlighted the market review, quarterly performance, and...
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Third Quarter Earnings Conference Call.
Adaptive Biotechnologies (ADPT) Poised for $33.7M Windfall on Genentech Deal Termination
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is one of the must-buy small-cap stocks to invest in.
10 Must-Buy Small-Cap Stocks to Invest In
Large-cap tech giants have been the catalyst behind the US equity market rallying to record highs.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2025 Financial Results Conference Call.
Adaptive Biotechnologies Corporation (ADPT) Rose on Solid Results
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The U.S.
Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers.
Hedge Fund Resource Center Billionaire Hedge Funds
